HealthMelanoma cancer vaccine shows promise in late-stage clinical trial

A new melanoma vaccine is producing promising results in a late-stage trial. The treatment combines immunotherapy with mRNA technology, using mutations identified in tumor cells removed during surgery to create a personalized vaccine designed to generate more cancer-fighting immune cells.